The Bleeding Edge Reader, $1.2 trillion... That's how much this little-known FDA move has pumped into biotechnology stocks. It's fueling a growing bull run in the sector. It's behind 9 of the top 10 best-selling biotechs of the 21st century. All companies that have generated over $100 billion EACH. And get this... Experts predict it could soon unleash another trillion. And I've discovered one company I believe stands to profit most from this next round of wealth. Click here for the full story. Regards, Jeff Brown Editor, The Near Future Report |
Tidak ada komentar:
Posting Komentar